United States · Bill · HR
H.R. 8624 (116th)
Protecting Access to Innovation During COVID–19 Act
Introduced
16 October 2020
Last action
16 October 2020 · Introduced
Status
Referred to the Committee on Energy and Commerce, and in addition to the Committee on Ways and Means, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.
Sponsors
Brad Wenstrup, Sanford Bishop, Rep. Harris, Andy [R-MD-1], Kenny Marchant, Rep. Kelly, Mike [R-PA-16], Rep. Fitzpatrick, Brian K. [R-PA-1], Richard Hudson
Subjects
Healthcare
Source updated
3 January 2025
Summary
Protecting Access to Innovation During COVID-19 Act This bill allows the Centers for Medicare & Medicaid Services (CMS) to extend the duration of pass-through status (i.e., additional payment) for certain drugs and devices under the Medicare prospective payment system for hospital outpatient department services. Specifically, the CMS may extend the pass-through status of drugs and devices that received such status during the public health emergency relating to COVID-19 (i.e., coronavirus disease 2019) if their cost cannot be accurately calculated due to the effects of COVID-19. The bill's provisions apply to drugs and devices that had pass-through status during any portion of the public health emergency period, including those for which such status has already expired.
This text is taken from the official record. PoliticalRepo does not editorialize.
Timeline
16 October 2020
Introduced
Referred to the Committee on Energy and Commerce, and in addition to the Committee on Ways and Means, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.
Source: IntroReferral
16 October 2020
Introduced
Introduced in House
Source: IntroReferral
16 October 2020
Introduced
Introduced in House
Source: IntroReferral
Votes
No vote records are attached yet.
Versions
- Introduced in House · 16 October 2020 · Official file
Documents
3 official files
Introduced in House (text)
Introduced in House (text)
Introduced in House · EN · 16 October 2020
Introduced in House (PDF)
Introduced in House · EN · 16 October 2020
Introduced in House
summary · EN · 16 October 2020
Sponsors
- Brad Wenstrup · R · Sponsor
- Sanford Bishop · D · Sponsor
- Rep. Harris, Andy [R-MD-1] · R · Cosponsor
- Kenny Marchant · R · Cosponsor
- Rep. Kelly, Mike [R-PA-16] · R · Cosponsor
- Rep. Fitzpatrick, Brian K. [R-PA-1] · R · Cosponsor
- Richard Hudson · R · Cosponsor
- · hswm00 · Standing
- · hsif00 · Standing
Related records
Sources
PoliticalRepo is an index and interpretation layer, not the authoritative legal source.
- Official source: https://www.congress.gov/bill/116th-congress/house-bill/8624
- Open data entity: https://api.congress.gov/v3/bill/116/hr/8624
- us · 116-hr-8624 · source updated 3 January 2025